Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026

In this episode, experts discuss the rapidly evolving bladder cancer treatment landscape, including new options for BCG-unresponsive disease, emerging perioperative regimens, and the growing role of biomarkers and multidisciplinary care in guiding treatment decisions.